BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.7x
Contraction
Streak
4 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -28.44% |
| 2024 | -22.05% |
| 2023 | 15.36% |
| 2022 | 46.32% |
| 2021 | 242.47% |
| 2020 | 42.38% |
| 2019 | -29.96% |
| 2018 | 69.16% |
| 2017 | -12.01% |
| 2016 | -28.61% |